Wednesday, 7 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Get Alerts

Biocon Ltd

NSE: BIOCON · BSE: 532523 · Pharmaceuticals & Biotechnology · 57 announcements

Biocon Ltd news stories on ALFA NewsRead the news →
Share price
₹360.70
Market cap
₹58,783 Cr
Revenue (annual)
₹16,927 Cr
Net profit (annual)
₹385.6 Cr
P/E (TTM)
118.7×Sector 47.4×
Promoter holding
44.68%-0.23% QoQ
FII holding
8.14%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Regulatory Approval 6Earnings Call 6Annual General Meeting 6Other Announcement 4Capital Structure Change 4Business Update 4New Order Win 3Management Change 3Fund Raise 3Financial Results 3Results Update 2Merger & Restructuring 2Board Meeting Outcome 2Board Meeting Date 2Acquisition 2Product Launch 1Price Movement Clarification 1Dividend 1Annual Report 1

Time

All time Last 1 weekLast 1 monthLast 2 monthsLast 3 monthsLast 6 monthsLast 1 year

2 announcements with these filters

19:47 IST NSE
Board Meeting Outcome

Biocon Board Meeting Outcome

Biocon Limited has scheduled a Board Meeting on May 7, 2026, to consider audited standalone and consolidated financial results for the year ended March 31, 2026. The board will also consider a recommendation for a final dividend. The trading window for designated persons remains closed until May 9, 2026.

Read the filing ↗
19:41 IST BSE
Board Meeting Outcome

Biocon Board Meeting Outcome

Biocon Ltd will hold a Board Meeting on May 07, 2026, to approve audited financial results for the fiscal year ended March 31, 2026, and recommend a dividend. An earnings conference call is scheduled for May 08, 2026. The trading window for designated persons remains closed until May 09, 2026.

Read the filing ↗